Market Overview:
The global Silibinin market is expected to grow at a CAGR of XX% and reach a value of USD XX million by 2030. The market is segmented on the basis of type, application and region. On the basis of type, the market is segmented into Silybin A, Silybin B and Mixture of A and B. On the basis of application, the market is segmented into Medical, Health Care and Others. The medical sector dominates the Silibinin market with a shareofXX%.
Product Definition:
Silibinin is a natural product derived from the milk thistle plant. It has been used for centuries to treat a variety of liver diseases. Silibinin is currently being studied as a possible treatment for cancer, hepatitis C, and other conditions.
Silybin A:
Silybin A is a bioactive compound extracted from silymarin, the main constituent of milk thistle. Silybin A has been found to be more effective than conventional drugs in treating liver diseases such as nonalcoholic steatohepatitis and hepatitis C virus (HCV) infection. It also exhibited antiviral properties against HCV leading to its interest in the development of anti-HCV agents.
Silybin B:
Silybin B is a bioactive compound extracted from the milk thistle plant. It has been reported to possess anti-oxidant, anti-microbial and anti-tumor properties. The product is marketed as a dietary supplement in various forms including tablets, capsules and liquid extract. Silybinin content present in the different products varies with respect to concentration which ranges between 10% - 25%.
Application Insights:
Health care was the largest application segment in 2016 and is expected to grow at a CAGR of XX% from 2017 to 2030. The product finds use as an anti-inflammatory, antioxidant, and anti-aging agent among other applications. It has been used for the treatment of cardiovascular diseases, osteoarthritis, rheumatoid arthritis as well as skin disorders such as acne vulgaris and eczema.
The medical segment accounted for USD 391 million in 2016 owing to extensive usage in various medical applications such as diabetes mellitus type 2 prevention therapy (for reducing oxidative stress), cardioprotection therapy against heart attacks & strokes (by decreasing inflammation), neuroprotective & neurodegenerative therapies against brain injuries/diseases including Alzheimer¢â‚¬â„¢s disease which is expected to drive growth over the forecast period.
Regional Analysis:
Asia Pacific was the largest regional market in 2017 and accounted for a share of more than 30%. The presence of key manufacturers coupled with high demand from countries such as Japan, China, South Korea, and India is anticipated to drive the market growth. In addition, increasing geriatric population prone to various diseases along with growing awareness about silibinin benefits are expected to fuel the product demand over the forecast period.
The Asia Pacific region is also anticipated to register significant growth due to rising healthcare expenditure by governments as well as private sectors in order to improve public health outcomes. Moreover, supportive government policies aimed at improving access for patients suffering from rare disorders are expected boost product consumption over the forecast period. Increasing geriatric population prone to various diseases such as cancer and diabetes is further expected propel industry expansion over next eight years (2018-2030).
Growth Factors:
- Increasing demand for herbal supplements and nutraceuticals
- Rising awareness about the health benefits of Silibinin
- Growing number of research studies supporting the use of Silibinin for various health conditions
- increasing investment in R&D by leading players to develop new formulations and delivery forms of Silibinin
- Launch of innovative products with better efficacy and safety profile by key players
Scope Of The Report
Report Attributes
Report Details
Report Title
Silibinin Market Research Report
By Type
Silybin A, Silybin B, Mixture of A and B
By Application
Medical, Health Care, Others
By Companies
Xinzhou City Advcom Trading., PANJIN HUACHENG PHARMACEUTICAL CO.,LTD, Shaanxi NHK Technology Co.,Ltd., Shreedha Phyto Extracts, Nutra Green Biotechnology Co.,Ltd., Panjin Huacheng Pharmacy Co.,Ltd., FYZ CO.LTD.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Silibinin Market Report Segments:
The global Silibinin market is segmented on the basis of:
Types
Silybin A, Silybin B, Mixture of A and B
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical, Health Care, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Xinzhou City Advcom Trading.
- PANJIN HUACHENG PHARMACEUTICAL CO.,LTD
- Shaanxi NHK Technology Co.,Ltd.
- Shreedha Phyto Extracts
- Nutra Green Biotechnology Co.,Ltd.
- Panjin Huacheng Pharmacy Co.,Ltd.
- FYZ CO.LTD.
Highlights of The Silibinin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Silybin A
- Silybin B
- Mixture of A and B
- By Application:
- Medical
- Health Care
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Silibinin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Silibinin is a flavonoid found in the roots of plants such as dandelion and burdock. It has been shown to have anti-inflammatory properties, and may be helpful in treating conditions such as arthritis.
Some of the major players in the silibinin market are Xinzhou City Advcom Trading., PANJIN HUACHENG PHARMACEUTICAL CO.,LTD, Shaanxi NHK Technology Co.,Ltd., Shreedha Phyto Extracts, Nutra Green Biotechnology Co.,Ltd., Panjin Huacheng Pharmacy Co.,Ltd., FYZ CO.LTD..
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Silibinin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Silibinin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Silibinin Market - Supply Chain
4.5. Global Silibinin Market Forecast
4.5.1. Silibinin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Silibinin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Silibinin Market Absolute $ Opportunity
5. Global Silibinin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Silibinin Market Size and Volume Forecast by Type
5.3.1. Silybin A
5.3.2. Silybin B
5.3.3. Mixture of A and B
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Silibinin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Silibinin Market Size and Volume Forecast by Application
6.3.1. Medical
6.3.2. Health Care
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Silibinin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Silibinin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Silibinin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Silibinin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Silibinin Demand Share Forecast, 2019-2026
9. North America Silibinin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Silibinin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Silibinin Market Size and Volume Forecast by Application
9.4.1. Medical
9.4.2. Health Care
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Silibinin Market Size and Volume Forecast by Type
9.7.1. Silybin A
9.7.2. Silybin B
9.7.3. Mixture of A and B
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Silibinin Demand Share Forecast, 2019-2026
10. Latin America Silibinin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Silibinin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Silibinin Market Size and Volume Forecast by Application
10.4.1. Medical
10.4.2. Health Care
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Silibinin Market Size and Volume Forecast by Type
10.7.1. Silybin A
10.7.2. Silybin B
10.7.3. Mixture of A and B
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Silibinin Demand Share Forecast, 2019-2026
11. Europe Silibinin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Silibinin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Silibinin Market Size and Volume Forecast by Application
11.4.1. Medical
11.4.2. Health Care
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Silibinin Market Size and Volume Forecast by Type
11.7.1. Silybin A
11.7.2. Silybin B
11.7.3. Mixture of A and B
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Silibinin Demand Share, 2019-2026
12. Asia Pacific Silibinin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Silibinin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Silibinin Market Size and Volume Forecast by Application
12.4.1. Medical
12.4.2. Health Care
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Silibinin Market Size and Volume Forecast by Type
12.7.1. Silybin A
12.7.2. Silybin B
12.7.3. Mixture of A and B
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Silibinin Demand Share, 2019-2026
13. Middle East & Africa Silibinin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Silibinin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Silibinin Market Size and Volume Forecast by Application
13.4.1. Medical
13.4.2. Health Care
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Silibinin Market Size and Volume Forecast by Type
13.7.1. Silybin A
13.7.2. Silybin B
13.7.3. Mixture of A and B
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Silibinin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Silibinin Market: Market Share Analysis
14.2. Silibinin Distributors and Customers
14.3. Silibinin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Xinzhou City Advcom Trading.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. PANJIN HUACHENG PHARMACEUTICAL CO.,LTD
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Shaanxi NHK Technology Co.,Ltd.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Shreedha Phyto Extracts
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nutra Green Biotechnology Co.,Ltd.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Panjin Huacheng Pharmacy Co.,Ltd.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. FYZ CO.LTD.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook